Infectivity of Norovirus in Groundwater-Human Challenge Study
NCT00313404 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13
Last updated 2013-11-19
Summary
Norwalk virus and related "Norwalk-like viruses" are the most common cause of outbreaks of stomach sickness (nausea, vomiting, diarrhea) in older children and adults in the United States. These viruses are sometimes found in drinking water, ice, shellfish and in other foods. They can be spread easily from contact with water, food, objects or hands that have even small amounts of feces from someone who was sick.
The purpose of this research study is to see how long Norwalk virus can survive in water and still be able to cause sickness. When this is determined the researchers will be able to recommend risk levels for norovirus contaminated waters. Another purpose for this study is to see how a person's body's immune cells respond to Norwalk virus in the body. During this study volunteers will receive a dose of Norwalk virus in water that may make them sick.
Conditions
- Healthy
Interventions
- BIOLOGICAL
-
Safety tested norovirus inoculum
This is a safety tested live infectious norovirus inoculum that has been placed in groundwater that meets EPA drinking water standards
Sponsors & Collaborators
- collaborator OTHER
-
Emory University
lead OTHER
Principal Investigators
-
Christine Moe, PhD · Emory University
-
George M Lyon III, MD, MMSc · Emory University
-
Kellogg Schwab, PhD · Johns Hopkins University
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-02-28
- Primary Completion
- 2007-01-31
- Completion
- 2011-04-30
Countries
- United States
Study Locations
More Related Trials
-
Dose Range Evaluation of Norovirus Challenge Pool (GII.4, CIN-1)
NCT01435811 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study to Determine the Optimal Human Challenge Dose for a Norovirus GII.4 Challenge Stock (CIN-1)
NCT02337842 ·Status: WITHDRAWN ·Phase: PHASE1
-
Applying Nutrient Drink Test in Understanding Pathophysiology of CVS
NCT03470181 ·Status: COMPLETED
-
Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department
NCT00590317 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer
NCT00020657 ·Status: COMPLETED ·Phase: PHASE3
-
Vestibular Dysfunction as a Cause of Chronic Nausea & Vomiting: A Follow up Survey
NCT01378351 ·Status: TERMINATED
-
Auriculotherapy and Acupuncture's Treatment for Chemotherapy-induced Nausea and Vomiting (CINV)
NCT02767791 ·Status: COMPLETED ·Phase: NA
-
Pedialyte or Gatorade for Viral Gastroenteritis in Adults: a Randomized, Controlled Trial
NCT00257374 ·Status: COMPLETED ·Phase: NA
-
Adherence to the Antiemesis National Comprehensive Cancer Network (NCCN) Guideline
NCT03740672 ·Status: UNKNOWN
-
Effect of Ginger on Nausea and Vomiting During Acute Gastroenteritis in Children
NCT02701491 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Disintegrating Ondansetron Tablet to Reduce Vomiting From Gastroenteritis in a Pediatric Emergency Department
NCT00120744 ·Status: COMPLETED ·Phase: NA
-
Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and Vomiting
NCT00642512 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of TAK-951 in Participants With Cyclic Vomiting Syndrome (CVS)
NCT06768658 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of TAK-105 in Healthy Adults
NCT04964258 ·Status: COMPLETED ·Phase: PHASE1
-
Topical Capsaicin for Cyclical Vomiting
NCT03223350 ·Status: COMPLETED ·Phase: PHASE2
-
Immediate Nausea and Vomiting After the Administration of Non-ionic Contrast Media
NCT03019341 ·Status: COMPLETED
-
Seasickness Susceptability and Vestibular Time Constant
NCT05640258 ·Status: COMPLETED ·Phase: NA
-
Noninvasive Markers of Functional Nausea in Children
NCT03593811 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative Nausea And Vomiting
NCT00108095 ·Status: COMPLETED ·Phase: PHASE2
-
EMDR Treatment of Conditioned Nausea and Vomiting in Cancer Survivors
NCT06769165 ·Status: RECRUITING ·Phase: NA
-
Ondansetron Administration to WELL Children With Gastroenteritis Associated Vomiting in EDs in Pakistan
NCT01870635 ·Status: COMPLETED ·Phase: PHASE4
-
Ginger Control of Chemotherapy Induced Nausea and Vomiting
NCT00065221 ·Status: COMPLETED ·Phase: PHASE2
-
Bioavailability Study of Anti Nausea Medication With and Without Food (EUR-1025)
NCT00981487 ·Status: COMPLETED ·Phase: PHASE1
-
Cortical Excitability in Cyclic Vomiting Syndrome
NCT05256160 ·Status: RECRUITING ·Phase: NA
-
Thumbtack Needle in the Treatment of NVP
NCT06566274 ·Status: RECRUITING ·Phase: NA